|
1
|
Rainusso N, Wang LL and Yustein JT: The
adolescent and young adult with cancer: state of the art-bone
tumors. Curr Oncol Rep. 15:296–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Omer N, Le Deley MC, Piperno-Neumann S,
Marec-Berard P, Italiano A, Corradini N, Bellera C, Brugières L and
Gaspar N: Phase-II trials in osteosarcoma recurrences: A systematic
review of past experience. Eur J Cancer. 75:98–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goedhart LM, Gerbers JG, Ploegmakers JJ
and Jutte PC: Delay in diagnosis and its effect on clinical outcome
in high-grade sarcoma of bone: A referral oncological centre study.
Orthop Surg. 8:122–128. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Z, Tang Y, Xing W, Dong W and Wang Z:
LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion
and migration by regulating Notch1 signaling and
epithelial-mesenchymal transition. Exp Mol Pathol. 104:19–25. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YJ, Wu H and Shen XZ: The
ubiquitin-proteasome system and its potential application in
hepatocellular carcinoma therapy. Cancer Lett. 379:245–252. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pickart CM: Mechanisms underlying
ubiquitination. Annu Rev Biochem. 70:503–533. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sacco JJ, Coulson JM, Clague MJ and Urbé
S: Emerging roles of deubiquitinases in cancer-associated pathways.
IUBMB Life. 62:140–157. 2010.PubMed/NCBI
|
|
8
|
Komander D, Clague MJ and Urbé S: Breaking
the chains: Structure and function of the deubiquitinases. Nat Rev
Mol Cell Biol. 10:550–563. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou F, Xie F, Jin K, Zhang Z, Clerici M,
Gao R, van Dinther M, Sixma TK, Huang H, Zhang L and Ten Dijke P:
USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP
signaling. EMBO J. 36:1623–1639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang Y, Pan XW, Li L, Chen L, Liu X, Lu
JL, Zhu XM, Huang H, Yang QW, Ye JQ, et al: Overexpression of USP39
predicts poor prognosis and promotes tumorigenesis of prostate
cancer via promoting EGFR mRNA maturation and transcription
elongation. Oncotarget. 7:22016–22030. 2016.PubMed/NCBI
|
|
11
|
Wang S, Juan J, Zhang Z, Du Y, Xu Y, Tong
J, Cao B, Moran MF, Zeng Y and Mao X: Inhibition of the
deubiquitinase USP5 leads to c-Maf protein degradation and myeloma
cell apoptosis. Cell Death Dis. 8:e30582017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meulmeester E, Maurice MM, Boutell C,
Teunisse AF, Ovaa H, Abraham TE, Dirks RW and Jochemsen AG: Loss of
HAUSP-mediated deubiquitination contributes to DNA damage-induced
destabilization of Hdmx and Hdm2. Mol Cell. 18:565–576. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meulmeester E, Pereg Y, Shiloh Y and
Jochemsen AG: ATM-mediated phosphorylations inhibit Mdmx/Mdm2
stabilization by HAUSP in favor of p53 activation. Cell Cycle.
4:1166–1170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cummins JM, Rago C, Kohli M, Kinzler KW,
Lengauer C and Vogelstein B: Tumour suppression: Disruption of
HAUSP gene stabilizesp53. Nature. 428(1): p following.
4862004.PubMed/NCBI
|
|
15
|
Colland F, Formstecher E, Jacq X, Reverdy
C, Planquette C, Conrath S, Trouplin V, Bianchi J, Aushev VN,
Camonis J, et al: Small-molecule inhibitor of USP7/HAUSP ubiquitin
protease stabilizes and activates p53 in cells. Mol Cancer Ther.
8:2286–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao
Q, Shen ZZ, Huang XY, Chen H, Yu DD, et al: Ubiquitin-specific
protease 7 accelerates p14(ARF) degradation by deubiquitinating
thyroid hormone receptor-interacting protein 12 and promotes
hepatocellular carcinoma progression. Hepatology. 61:1603–1614.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turley EA, Veiseh M, Radisky DC and
Bissell MJ: Mechanisms of disease: Epithelial-mesenchymal
transition-does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol. 5:280–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Liu Y, Zou J, Yan L, Du W, Zhang
Y, Sun H, Lu P, Geng S, Gu R, et al: Tetrahydrocurcumin induces
mesenchymal-epithelial transition and suppresses angiogenesis by
targeting HIF-1α and autophagy in human osteosarcoma. Oncotarget.
8:91134–91149. 2017.PubMed/NCBI
|
|
20
|
Shen S, Huang K, Wu Y, Ma Y, Wang J, Qin F
and Ma J: A miR-135b-TAZ positive feedback loop promotes
epithelial-mesenchymal transition (EMT) and tumorigenesis in
osteosarcoma. Cancer Lett. 407:32–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP. EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tavana O, Li D, Dai C, Lopez G, Banerjee
D, Kon N, Chen C, Califano A, Yamashiro DJ, Sun H and Gu W: HAUSP
deubiquitinates and stabilizes N-Myc in neuroblastoma. Nature Med.
22:1180–1186. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Q, Ma S, Song N, Li X, Liu L, Yang S,
Ding X, Shan L, Zhou X, Su D, et al: Stabilization of histone
demethylase PHF8 by USP7 promotes breast carcinogenesis. J Clin
Invest. 126:2205–2220. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hazan RB, Qiao R, Keren R, Badano I and
Suyama K: Cadherin switch in tumor progression. Ann N Y Acad Sci.
1014:155–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and WNT/β-catenin signalling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Angers S and Moon RT: Proximal events in
Wnt signal transduction. Nat Rev Mol Cell Biol. 10:468–477. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cadigan KM and Waterman ML: TC F/LEFs and
Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol.
4(pii): a0079062012.PubMed/NCBI
|
|
28
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang Z, Jiang C and Fang J: Up-regulated
lnc-SNHG1 contributes to osteosarcoma progression through
sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin
pathway. Biochem Biophys Res Commun. 495:238–245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv YF, Dai H, Yan GN, Meng G, Zhang X and
Guo QN: Downregulation of tumor suppressing STF cDNA 3 promotes
epithelial-mesenchymal transition and tumor metastasis of
osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway.
Cancer Lett. 373:164–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Novellasdemunt L, Foglizzo V, Cuadrado L,
Antas P, Kucharska A, Encheva V, Snijders AP and Li VSW: USP7 Is a
tumor-specific WNT activator for APC-mutated colorectal cancer by
mediating β-catenin deubiquitination. Cell Rep. 21:612–627. 2017.
View Article : Google Scholar : PubMed/NCBI
|
